The medicolegal issue of tissue plasminogen activator in ischemic stroke: A review of judiciary decrees in Taiwan

Acta Neurologica Taiwanica

Volumn 20, Issue 3, 2011, Pages 163-171

  Chen, Wei Hsi ^a,b,c   Lin, Hung Sheng ^a   Chen, Chien I ^d   Chou, Min Shon ^b   Liou, Chia Wei ^a   Chen, Shun Sheng ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

^c Medical Regulation Committee   (Taiwan)

^d KAINAN UNIVERSITY   (Taiwan)

Author keywords

Ischemic stroke; Medical litigation; Medical malpractice; Non neurologist; Tissue plasminogen activator

Indexed keywords

ALTEPLASE; ANTIBIOTIC AGENT; ANTIDIABETIC AGENT; ANTIPYRETIC AGENT; ANTITUSSIVE AGENT; FENTANYL; INSULIN; MORPHINE;

ADULT; AGED; ANTICOAGULANT THERAPY; BASILAR ARTERY OBSTRUCTION; BLOOD PRESSURE REGULATION; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN STEM INFARCTION; CAUSE OF DEATH; CLINICAL ARTICLE; CONSCIOUSNESS DISORDER; CONSERVATIVE TREATMENT; COUGHING; DELAYED DIAGNOSIS; DIAGNOSTIC ERROR; DRUG CONTRAINDICATION; FEMALE; FEVER; HEMIPARESIS; HEMIPLEGIA; HUMAN; HYPERGLYCEMIA; IRRITABILITY; MALE; MALPRACTICE; MEDICOLEGAL ASPECT; MUSCLE WEAKNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PAIN; PERSISTENT VEGETATIVE STATE; PHYSIOTHERAPY; PNEUMONIA; PONS; QUADRIPLEGIA; REVIEW; SEPSIS; SORE THROAT; STROKE;

AGED; BRAIN ISCHEMIA; FEMALE; HUMANS; MALE; MALPRACTICE; MIDDLE AGED; RECOMBINANT PROTEINS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 81855198027     PISSN: 10196099     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Anonymous. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-1587.
2. Brott TG, Haley EC Jr, Levy DE, Barsan W, Broderick J, Sheppard GL, Spilker J, Kongable GL, Massey S, Reed R. Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 1992;23:632-640.
3. Haley EC Jr, Levy DE, Brott TG, Sheppard GL, Wong MC, Kongable GL, Torner JC, Marler JR. Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Stroke 1992;23:641-645.
4. Label and Approval History (Activase), FDA. From: http://www.accessdata. fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Label- ApprovalHistory#apphist (last date of visit: 2010/09/20).
5. Chen WH. Payment regulation of thrombolytic agents in ischemic stroke by Central Health Insurance Bureau, Taiwan (I) -An evaluation of limitation of inclusive and exclusive criteria [Chin]. National Heath Insurance Dispute Mediation Report (in press).
6. Chen WH. Payment regulation of thrombolytic agents in ischemic stroke by Central Health Insurance Bureau, Taiwan (II)-An evaluation of limitation of accessories and expense Application [Chin]. National Heath Insurance Dispute Mediation Report (in press).
7. Taiwan Stroke Society. Taiwan guidelines for the management of stroke, 2008. From: http://www.stroke.org.tw/guideline/file/2008.pdf (last date of visit: 2010/09/20).
8. Liang BA, Lew R, Zivin JA. Review of tissue plasminogen activator, ischemic stroke, and potential legal issues. Arch Neurol 2008;65:1429-1433.
9. Liang BA, Zivin JA. Empirical characteristics of litigation involving tissue plasminogen activator and ischemic stroke. Ann Emerg Med 2008;52:160-164.
10. Weintraub MI. Thrombolysis (tissue plasminogen activator) in stroke: a medicolegal quagmire. Stroke 2006;37:1917-1922. (Pubitemid 44297752)
11. Schiff GD, Hasan O, Kim S, Abrams R, Cosby K, Lambert BL, Elstein AS, Hasler S, Kabongo ML, Krosnjar N, Odwazny R, Wisniewski MF, McNutt RA. Diagnostic error in medicine: analysis of 583 physician-reported errors. Arch Intern Med 2009;169:1881-1887.
12. de la Torre-Laviana FJ, Moniche-Alvarez F, Palomino-García A, Cayuela-Domínguez A, Vigil E, Jiménez MD. False diagnoses of strokes in emergency departments [Spa]. Rev Neurol 2010;50:463-469.
13. Yu RF, San Jose MC, Manzanilla BM, Oris MY, Gan R. Sources and reasons for delays in the care of acute stroke patients. J Neurol Sci 2002;199:49-54. (Pubitemid 34663835)
14. Kleinmann v. St. Peter's Hospital, 298 A.D.2d 675, 748 N.Y.S.2d 814, 2002.